Role of serology in the diagnosis of lyme disease

JAMA

Volumn 282, Issue 1, 1999, Pages 62-66

  Brown, S Lori ^a,b   Hansen, Sharon L ^a   Langone, John J ^a  

^a Ctr Devices Radiological Hlth   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BORRELIA BURGDORFERI; DIAGNOSTIC ERROR; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNOFLUORESCENCE TEST; LYME DISEASE; PRIORITY JOURNAL; SENSITIVITY AND SENSIBILITY; SERODIAGNOSIS;

EID: 0344731049     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.1.62     Document Type: Article

References (32)

1. Steere AC. Lyme disease. N Engl J Med. 1989;321: 586-596.
2. Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med. 1983;308:733-740.
3. Benach JL, Bosler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med. 1983;308:740-742.
4. 21 CFR §807.92(5) and §(6)(b)(2)(ii)(B).
5. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 1995;44:590-591.
6. Food and Drug Administration. FDA Advisory Panel Meeting, 1996: Microbiology Devices Panel Medical Devices Advisory Committee, Open Session, Volume II. Washington, DC: Food and Drug Administration; January 26, 1996.
7. FDA Public Health Advisory. Assays for antibodies to Borrelia burgdorferi; limitations, use and interpretation for supporting clinical diagnosis of Lyme disease. Available at: http://www.fda.gov/cdrh/ lyme.html. Accessed May 27, 1999.
8. Dattwyler RJ, Luft JL. Borrelia burgdorferi. In: Gorback SL, Bartlett JG, Blacknow NL, eds. Infectious Disease. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1998.
9. Lyme disease - United States, 1996. MMWR Morb Mortal Wkly Rep. 1997;46:531-535.
10. Duray PH, Chandler FW. Lyme disease. In: Connor DH, Chandler FW, Schwartz DA, Manz HJ, Lach EE, eds. Pathology of Infectious Disease, I. Stamford, Conn: Appleton & Lange; 1997.
11. American College of Physicians. Guidelines for laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med. 1997;127:1106-1108.
12. Schmitz JL, Powell CS, Folds JD. Comparison of seven commercial kits for detection of antibodies to Borrelia burgdorferi. Eur J Clin Microbiol Infect Dis. 1993;12:419-424.
13. Tierno PM Jr, Cadet-Legros J. Methods comparison for diagnosis of Lyme disease. Lab Med. 1996; 27:542-546.
14. Sigal LH. Lyme disease: a review of aspects of its immunology and immunopathogenesis. Annu Rev Immunol. 1997;15:63-92.
15. Tugwell P, Dennis DT, Weinstein A, et al. Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med. 1997;127:1109-1123.
16. Sigal LH. Pitfalls in the diagnosis and management of Lyme disease. Arthritis Rheum. 1998;41:195-204.
17. Nocton JJ, Steere AC. Lyme disease. Adv Intern Med. 1995;40:69-117.
18. Magnarelli LA, Miller JN, Anderson JF, Riviere GR. Cross-reactivity of nonspecific treponemal antibody in serologic tests for Lyme disease. J Clin Microbiol. 1990;28:1276-1279.
19. Hofman H. Lyme borreliosis - problems of seralogical diagnosis. Infection. 1996;24:470-472.
20. Schwartz BS, Goldstein MD, Ribeiro JMC, Schulze TL, Shahied SI. Antibody testing in Lyme disease: a comparison of results in four laboratories. JAMA. 1989;262:3431-3434.
21. Luger SW, Krauss E. Serologic tests for Lyme disease: interlaboratory variability. Arch Intern Med. 1990; 150:761-763.
22. Bakken LL, Case KL, Callister SM, Bourdeau NJ, Schell RF. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology. JAMA. 1992;268:891-895.
23. Bakken LL, Callister SM, Wand PJ, Schell RF. Interlaboratory comparison of test results for detection of Lyme disease by 516 participants in the Wisconsin State Laboratory of Hygiene/College of American Pathologists Proficiency Testing Program. J Clin Microbiol. 1997;35:537-543.
24. Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GB. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol. 1996;34:1-9.
25. Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG. Seronegative Lyme disease. N Engl J Med. 1988;319:1441-1446.
26. Fix AD, Strickland GT, Grant J. Tick bites and Lyme disease in an endemic setting: problematic use of serologic testing and prophylactic antibiotic therapy. JAMA. 1998;279:206-210.
27. Reid MC, Schoen RT, Evans J, Rosenberg JC, Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med. 1998;128:354-362.
28. Strickland GT, Karp AC, Mathews A, Peña CA. Utilization and cost of serologic tests for Lyme disease in Maryland. J Infect Dis. 1997;176:819-821.
29. Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA. 1993;269: 1812-1816.
30. Sigal LH, Zahradnik JM, Lavin P, et al, and the Recombinant Outer-Surface Protein A Lyme Disease Vaccine Consortium. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. N Engl J Med. 1998;339:216-222.
31. Steere AC, Sikand VK, Meurice F, et al, and the Lyme Disease Vaccine Group. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outersurface lipoprotein A with adjuvant. N Engl J Med. 1998;339:209-215.
32. Zhang Y-Q, Mathiesen D, Kolbert CP, et al. Borrelia burgdorferi enzyme-linked immunosorbent assay for discrimination of OspA vaccination from spirochete infection. J Clin Microbiol. 1997;35: 233-238.